Patanjali CEO Acharya Balkrishna on the controversy surrounding their supposed COVID-19 medicine 'Coronil' said that company has followed all procedures to manufacture the medicine Coronil.
Acharya said, "We applied for the licence based on classical evidence of the compounds used in the medicine.
We worked on the compounds and put out the results of the clinical trial before people, it was not an advertisement."
